Transcription of Genetic Testing for Hereditary Cancer Susceptibility Syndromes
{{id}} {{{paragraph}}}
Page 1 of 33 medical Coverage Policy: 0518 medical Coverage Policy Effective Date .. 7/15/2021 Next Review Date .. 7/15/2022 Coverage Policy Number .. 0518 Genetic Testing for Hereditary Cancer Susceptibility Syndromes Table of Contents Overview .. 2 Coverage Policy .. 2 General Criteria for Germline Pathogenic or Likely Pathogenic Variant Genetic Testing : Hereditary Cancer Susceptibility /Risk Assessment .. 2 Germline Testing Following Identification of a Somatic Pathogenic or Likely Pathogenic Variant .. 3 Germline Pathogenic or Likely Pathogenic Variant Genetic Testing for Hereditary Cancer Susceptibility Syndromes .
guidelines. In certain markets, delegated vendor guidelines may be used to support medical necessity and other coverage determinations.. Overview . This Coverage Policy addresses genetic testing for germline pathogenic or likely pathogenic variants related to hereditary cancer susceptibility syndromes.
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}